RICE Pharmaceuticals Overview

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

RICE Pharmaceuticals General Information

Description

Developer of remyelination therapies for neurodegenerative diseases based in the United States. The company's drug pipeline includes PDE4D inhibitors designed to repair myelin damage in conditions such as multiple sclerosis by stimulating the cells responsible for myelin production, enabling neurologists and specialty care providers to offer treatment options that target myelin restoration in patients where existing therapies manage symptoms but do not repair underlying nerve damage.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Amsterdam
  • Netherlands
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • Amsterdam
  • Netherlands

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RICE Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 29-Oct-2026 Completed Out of Business
1. Seed Round 06-Jun-2025 Completed Startup
To view RICE Pharmaceuticals’s complete valuation and funding history, request access »

RICE Pharmaceuticals FAQs

  • Where is RICE Pharmaceuticals headquartered?

    RICE Pharmaceuticals is headquartered in Amsterdam, Netherlands.

  • What industry is RICE Pharmaceuticals in?

    RICE Pharmaceuticals’s primary industry is Drug Discovery.

  • Is RICE Pharmaceuticals a private or public company?

    RICE Pharmaceuticals is a Private company.

  • What is RICE Pharmaceuticals’s current revenue?

    The current revenue for RICE Pharmaceuticals is .

  • How much funding has RICE Pharmaceuticals raised over time?

    RICE Pharmaceuticals has raised $150K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process